跳至主要内容
临床试验/JPRN-jRCT1080220995
JPRN-jRCT1080220995未知Unknown

Administration study as a part of research toward the influence of growth hormone releasing peptide GHRP-2 on detection of rhGH

Mitsubishi chemical Medience Corporation0 个研究点目标入组 15 人开始时间: 2010年2月5日最近更新:
适应症

试验速览

阶段
Unknown
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 40age old(—)
性别
Male

入选标准

  • Weight: more than 50 kg and under 66kg
  • BMI: more than 18.5 and under 25

排除标准

  • Hypersensitive to drugs,
  • A hystory of alcoholism of drug addiction,
  • Ethical or OTC pharmaceuticals administration within two before scheduled administration of the study,
  • Supplement, grapefruit or its products, or foods containing Hyperrium perforatum consumed within one week before scheduled administration of the study.
  • Not less than 200 ml of blood is collected within 30 days or not less than 400 ml of blood is collected within 90 days before scheduled administration of the study.

研究者

发起方
Mitsubishi chemical Medience Corporation

相似试验

Administration study as a part of research toward... | 临床试验